LYKA LABS
|
The Current P/S Ratio of LYKA LABS is 3.00.
Share Price | ₹116.4 | Jun 06,2025 |
Market Cap | ₹415.4 Cr | |
Sales-TTM | ₹138.5 Cr | TTM-Consolidated Results |
Price/Sales | 3.00x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of LYKA LABS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹415.4 Cr] as on Jun 06,2025
(/) Sales [ ₹138.5 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.00x ]
Thus, for LYKA LABS , the investors are currently willing to pay '3.00 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of LYKA LABS !
The chart below summarizes the trend in P/S Ratio of LYKA LABS over the last five years.
Historical PS (Price/Sales) ratio chart of LYKA LABS
PS Ratio Performance Analysis for LYKA LABS
- LYKA LABS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.01x.
- LYKA LABS 's operated at median p/e ratio of 2x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LYKA LABS 's p/e ratio peaked in Mar2023 at 3.45x.
- LYKA LABS 's p/e ratio hit its five-year low in Mar2020 of 0.59x.
How does LYKA LABS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
LYKA LABS | 138.5 | 3.00 | 415.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.67 | 403,076.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 18.58 | 173,924.0 |
CIPLA LTD | 27,547.6 | 4.41 | 121,456.0 |
TORRENT PHARMACEUTICALS LTD | 11,516.0 | 9.27 | 106,761.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.38 | 110,197.0 |
MANKIND PHARMA LTD | 12,279.3 | 7.91 | 97,097.4 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.16 | 96,598.5 |
LUPIN LTD | 22,707.9 | 4.02 | 91,302.6 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.13 | 67,413.6 |
ABBOTT INDIA LTD | 6,409.2 | 10.53 | 67,468.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs LYKA LABS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.13x |
Max industry PS | 18.58x |
Median industry PS | 4.41x |
Average industry PS | 6.82x |
You may also like the below Video Courses